Breaking News

You are here » Indian-Commodity  :  Commodities  :  Cardamom  :  Cardamom futures trade lower on MCX


Cardamom futures trade lower on MCX

Cardamom futures traded lower on MCX as investors trimmed their positions in the agri-commodity amid sluggish physical demand in the domestic spot market. Further, sufficient supplies amid increased physical arrivals from the major cardamom producing regions too fuelled the downtrend.

The contract for October delivery was trading at Rs 1139.20, down by 0.71% or Rs 8.20 from its previous closing of Rs 1147.40.The open interest of the contract stood at 803.00 lots.

The contract for November delivery was trading at Rs 1163.90, down by 0.45% or Rs 5.30 from its previous closing of Rs 1169.20. The open interest of the contract stood at 610.00 lots on MCX.

Related News

View all news

Cardamom futures trade lower on profit taking

Cardamom futures traded lower on MCX, as investors locked in their prevailing profits. Moreover, dip in buying from export and domestic markets amid prevailing higher price also added to downside.The contract......

Cardamom futures trade higher on firm demand

Cardamom futures traded higher on MCX, as market players accumulated their bets on low production prospects followed by firm demand from spot domestic markets. Moreover, tight inventory levels after heavy......

Cardamom futures decline on muted demand

Cardamom futures declined on MCX, as market participants trimmed their bets followed by muted demand from physical markets. Meanwhile, concerns about demand from UAE due to strict pesticide rule also weighed......

Top News

View all news

Karnataka Bank launches CASA campaign

Karnataka Bank has launched Current & Savings Accounts campaign (CASA) of FY 2018-19 and introduced a new SB scheme 'KBL SB - TASC' a specialized product for Trusts/Associates/Societies/Clubs.Under......

M&M's arm opens manufacturing hub in Bengaluru

Mahindra & Mahindra's (M&M) subsidiary -- Mahindra Electric Mobility has opened its electric technology manufacturing hub set up with an investment of Rs 100 crore in Bengaluru. The plant......

Venus Remedies reports positive result in Phase-3 Clinical Trials for ELORES

Venus Remedies has reported positive Top-Line results in its Phase-3 Clinical Trials for its flagship product ELORES. The results were presented at IDWeek 2018 in San Francisco. IDWeek is an annual scientific......